AKT1S1 and obesity due to melanocortin 4 receptor deficiency: Cell type specific mTORC1 inhibition with PRAS40, an endogenous mTORC1 component, is therefore a novel approach to prevent the deleterious consequences of chronic mTORC1 activation in obesity.